A phase 1b/2 study evaluating activity and tolerability of the BTK inhibitor ibrutinib in combination with ofatumumab in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and related diseases
Jaglowski, Samantha Mary, Jones, Jeffrey Alan, Flynn, Joseph M., Andritsos, Leslie A., Maddocks, Kami J., Woyach, Jennifer Ann, Blum, Kristie A., Grever, Michael R., Geyer, Susan Michelle, Heerema, Nyla A., Lozanski, Gerard, Stefanos, Mona, Hall, Nathan, Nagar, Veena, Munneke, Brian, West, Jamie-Sue, Neuenburg, Jutta, James, Danelle Frances, Johnson, Amy J., Byrd, John C.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Activity and Tolerability of Ibrutinib in Combination With Ofatumumab in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Jaglowski, Samantha M., MD, MPH, Jones, Jeffrey A., MD, MPH, Flynn, Joseph M., DO, MPH, Andritsos, Leslie A., MD, Maddocks, Kami J., MD, Woyach, Jennifer A., MD, Blum, Kristie A., MD, Grever, Michael R., MD, Geyer, Susan Michelle, PhD, Heerema, Nyla A., PhD, Lozanski, Gerard, MD, Stefanos, Mona, BS, Hall, Nathan, MD, PhD, Nagar, Veena, MD, Munneke, Brian, PhD, West, Jamie-Sue, Neuenburg, Jutta K., MD, PhD, James, Danelle F., MD, MAS, Johnson, Amy J., PhD, Byrd, John C., MD
Published in Clinical lymphoma, myeloma and leukemia (01.06.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.06.2015)
Get full text
Journal Article
A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment
Clifford, D B, McArthur, J C, Schifitto, G, Kieburtz, K, McDermott, M P, Letendre, S, Cohen, B A, Marder, K, Ellis, R J, Marra, C M
Published in Neurology (26.11.2002)
Published in Neurology (26.11.2002)
Get more information
Journal Article